NET PROFIT (x1000 SEK)
EMPLOYEES
Biomedrex AB
Closing information (x1000 SEK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
202
|
206
|
45 |
Earnings before taxes |
384
|
-830
|
-392 |
EBITDA |
581
|
-624
|
-347 |
Total assets |
15,970
|
14,893
|
6,756 |
Current assets |
199
|
1,072
|
832 |
Current liabilities |
3,767
|
3,157
|
995 |
Equity capital |
4,702
|
4,118
|
4,252 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
3
|
8
|
4 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency |
29.4%
|
27.7%
|
62.9% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
3.7%
|
-4.2%
|
-5.1% |
Current ratio |
5.3%
|
34.0%
|
83.6% |
Return on equity (ROE) |
8.2%
|
-20.2%
|
-9.2% |
Change turnover |
0
![]() |
0
|
-513 |
Change turnover % | -100% | ||
Chg. No. of employees |
-5
|
4
|
3 |
Chg. No. of employees % |
-63%
|
100%
|
300% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.